Neuro20 Technologies Corp.
PrivateLast Round
Seed
May 1, 2022
Total Funding Raised
$1.31M
Company Overview
Neuro20 Technologies Corp. is a medical device company that develops and manufactures wearable neuromuscular stimulation systems for rehabilitation and physical performance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuro20 Technologies Corp. Comparables
Compare Neuro20 Technologies Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AxioBionics | 78% | |
| Wiemspro | 74% | |
| CIONIC | 71% | |
Neuro20 Technologies Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2022 |
Neuro20 Technologies Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IntuitiveX | Seed |
| Tampa Bay Technology Incubator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2023
Grew 25% QoQ, from 12 to 15 employees.
- Nov 27, 2023
Grew 36% QoQ, from 11 to 15 employees.
Neuro20 Technologies Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuro20 Technologies Corp.'s valuation, stock price, and market status.